AU4427000A - Pharmaceutical compositions comprising apocodeine and/or its derivatives - Google Patents

Pharmaceutical compositions comprising apocodeine and/or its derivatives Download PDF

Info

Publication number
AU4427000A
AU4427000A AU44270/00A AU4427000A AU4427000A AU 4427000 A AU4427000 A AU 4427000A AU 44270/00 A AU44270/00 A AU 44270/00A AU 4427000 A AU4427000 A AU 4427000A AU 4427000 A AU4427000 A AU 4427000A
Authority
AU
Australia
Prior art keywords
apc
derivatives
male
pct
adhesive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44270/00A
Other languages
English (en)
Inventor
Mario Baraldi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unihart Corp
Original Assignee
Unihart Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unihart Corp filed Critical Unihart Corp
Publication of AU4427000A publication Critical patent/AU4427000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AU44270/00A 1999-05-13 2000-05-12 Pharmaceutical compositions comprising apocodeine and/or its derivatives Abandoned AU4427000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IE990389 1999-05-13
IE990389 1999-05-13
PCT/IE2000/000065 WO2000069416A1 (en) 1999-05-13 2000-05-12 Pharmaceutical compositions comprising apocodeine and/or its derivatives

Publications (1)

Publication Number Publication Date
AU4427000A true AU4427000A (en) 2000-12-05

Family

ID=11042062

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44270/00A Abandoned AU4427000A (en) 1999-05-13 2000-05-12 Pharmaceutical compositions comprising apocodeine and/or its derivatives

Country Status (7)

Country Link
EP (1) EP1175206A1 (ja)
JP (1) JP2002544221A (ja)
AU (1) AU4427000A (ja)
CA (1) CA2371551A1 (ja)
MX (1) MXPA01011480A (ja)
NO (1) NO20015519L (ja)
WO (1) WO2000069416A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1471395A (zh) * 2000-04-07 2004-01-28 ����ҽҩƷ���޹�˾ 阿扑***衍生物及其使用方法
SE0002934D0 (sv) 2000-08-17 2000-08-17 Axon Biochemicals Bv New aporphine esters and in their use in therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806341A (en) * 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
FI873429A (fi) * 1986-08-18 1988-02-19 Houston Biotechnology Oftalmologiska kompositioner foer behandling av nervdegenerationer.
PT914097E (pt) * 1996-03-12 2002-06-28 Alza Corp Composicao e forma de dosagem compreendendo antagonista de opioide

Also Published As

Publication number Publication date
NO20015519L (no) 2002-01-11
EP1175206A1 (en) 2002-01-30
JP2002544221A (ja) 2002-12-24
WO2000069416A1 (en) 2000-11-23
MXPA01011480A (es) 2002-06-04
NO20015519D0 (no) 2001-11-12
CA2371551A1 (en) 2000-11-23

Similar Documents

Publication Publication Date Title
JP2533211B2 (ja) 全身的経皮投与用医薬組成物
US20040202705A1 (en) Transdermal administration of huperzine
WO2007120868A2 (en) Bioavailability enhancement of lipophilic drug by use solvent system
US20120309823A1 (en) Percutaneous absorption preparations
JP2540019B2 (ja) 医薬組成物
US20120077836A1 (en) Methods of administering (4ar,10ar)-1-n-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo [g] quinoline-6,7-diol and related compounds across the oral mucosa, the nasal mucosa or the skin and pharmaceutical compositions thereof
US20080176913A1 (en) Transdermal compositions of pramipexole having enhanced permeation properties
AU764025B2 (en) Transdermal patch and topical compositions comprising propylnorapomorphine
WO2021098791A1 (zh) 一种含有美金刚的透皮贴剂
NO320050B1 (no) Transmukosale formuleringer av levosimendan og anvendelse derav til fremstilling av faramasoytisk preparat.
AU4427000A (en) Pharmaceutical compositions comprising apocodeine and/or its derivatives
CN112107561B (zh) 含有壳聚糖的药物制剂、药物透皮贴剂及其制备方法
CN115475152A (zh) 氟比洛芬的外用制剂及其制备方法
Walters et al. Dermal and Transdermal Drug Delivery Systems: An Overview and Recent Advancements
CN112057436A (zh) 含有脂质的药物制剂、药物透皮贴剂及其制备方法
JP3841628B2 (ja) 経皮吸収剤
Kruti et al. Novel Drug Delivery Approach: Transdermal Drug Delivery System–A Review
Walters et al. 1 Dermal Drug Delivery and Transdermal Systems
MXPA01000527A (en) Transdermal patch and topical compositions comprising propylnorapomorphine
Krishnarajan et al. RECENT APPROACHES OF TRANSDERMAL DRUG DELIVERY SYSTEM: A REVIEW
AU2013206198A1 (en) Methods of administering (4aR,10aR)-1-n-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline-6,7-diol and related compounds across the oral mucosa, the nasal mucosa or the skin and pharmaceutical compositions thereof
JP2017007994A (ja) 経皮吸収型製剤

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period